- 1 2 3 4 5 6 7 UNITED STATES DISTRICT COURT 8 EASTERN DISTRICT OF CALIFORNIA 9 10 RUSSELL WILSON, Case No. 1:20-cv-01753-SKO 11 Plaintiff, 12 v. ORDER ON PLAINTIFF’S SOCIAL 13 SECURITY COMPLAINT KILOLO KIJAKAZI, 14 Acting Commissioner of Social Security,1 15 Defendant. (Doc. 1) 16 17 _____________________________________/ 18 19 I. INTRODUCTION 20 Plaintiff Russell Wilson (“Plaintiff”) seeks judicial review of a final decision of the 21 Commissioner of Social Security (the “Commissioner” or “Defendant”) denying his application 22 for disability insurance benefits (“DIB”) under the Social Security Act (the “Act”). (Doc. 1.) The 23 matter is currently before the Court on the parties’ briefs, which were submitted, without oral 24 argument, to the Honorable Sheila K. Oberto, United States Magistrate Judge.2 25 /// 26 1 On July 9, 2021, Kilolo Kijakazi was named Acting Commissioner of the Social Security Administration. See 27 https://www.ssa.gov/history/commissioners.html. She is therefore substituted as the defendant in this action. See 42 U.S.C. § 405(g) (referring to the “Commissioner’s Answer”); 20 C.F.R. § 422.210(d) (“the person holding the Office 28 of the Commissioner shall, in [their] official capacity, be the proper defendant”). 1 2 Plaintiff was born on November 13, 1971, has a college education, and can communicate 3 in English. (Administrative Record (“AR”) 39, 40, 70, 84, 205, 273.) Plaintiff filed a claim for 4 DIB on January 24, 2018, alleging he became disabled on October 11, 2017, due to frontotemporal 5 dementia, Pick’s Disease, C4-C5 disc replacement, frontal lobe executive function control, 6 depression, generalized anxiety disorder, diabetes, constipation, fatigue, dizziness, poor balance, 7 weak grip, muscle spasms, lightheadedness, numbness, pain, sensitivity to chemicals and heat, skin 8 problems, slurred speech, insomnia, weakness, migraines, headaches, mood swings, flashbacks, 9 irritability, and obsessiveness. (AR 70–71, 84–85, 116, 122, 209, 218, 263, 276.) 10 A. Relevant Evidence of Record3 11 1. Medical Evidence 12 In July and August 2017, Plaintiff presented for a diagnostic evaluation by Bradley A. 13 Schuyler, Ph.D. due to concerns about possible attention deficient hyperactivity disorder (ADHD), 14 focus, memory, and facial twitching. (AR 333–44, 562–64, 573–75, 584–92, 595–603.) Dr. 15 Schuyler conducted mental status examinations of Plaintiff, and found he had normal appearance, 16 his “mentation” was within normal limited, and he had euthymic mood. (AR 334, 337, 340, 343, 17 563, 574, 585, 588, 591, 596, 599, 602.) Testing by Dr. Schuyler confirmed that he “does not have 18 an attention disorder,” but he did have “difficulties with nonverbal reasoning.” (AR 335, 338, 564, 19 575, 597, 600.) He was distracted by talking during testing, but was otherwise not impulsive and 20 did not appear hesitant. (AR 332.) 21 In October 2017, Plaintiff reported to his family physician Anthony Montana, M.D., that 22 he was having “difficulty with cognitive dysfunction and performing his usual customary work 23 activities because of inability to concentrate focus and have appropriate memory.” (AR 351, 375– 24 76.) His anxiety and depression were noted to be controlled by medication. (AR 351, 376.) Dr. 25 Montana’s mental examination of Plaintiff was normal, with normal mood, affect, and behavior. 26 (AR 352, 377.) That same month, Plaintiff complained of depression, anxiety, and lack of 27 28 3 Because the parties are familiar with the medical evidence, it is summarized here only to the extent relevant to the 1 concentration/forgetfulness. (AR 395, 533.) He reported taking benzodiazepine “for many years.” 2 (AR 395, 533.) He was dressed appropriately, well groomed, good hygiene, and cooperative and 3 had a “calm and relaxed” normal gait. (AR 396, 534.) Upon mental status examination, the 4 examiner noted Plaintiff spoke slowly and stammered, with difficulty finding words. (AR 396, 5 534.) His mood was noted as “normal and depressed.” (AR 396, 534.) His affect was normal and 6 thought process was organized, goal directed, and linear. (AR 396, 534.) Plaintiff was found to 7 be alert, with both long-term and short-term memory intact, good judgment, good insight, intact 8 reasoning, and full insight. (AR 396, 534.) 9 That same month, Plaintiff presented for a follow up appointment with Dr. Schuyler. (AR 10 543–46, 549–52.) Dr. Schuyler’s mental status examination of Plaintiff was normal, with euthymic 11 mood. (AR 544, 550.) After a discussion of Plaintiff’s neuropsychological evaluation testing, Dr. 12 Schuyler concluded that the results “validate the patient’s subjective complaints of experiencing 13 difficulties with memory and executive functions.” (AR 545, 551.) 14 Plaintiff reported having memory problems and “not doing well” in November 2017. (AR 15 394, 532.) He was advised, and understood, that use of benzodiazepine “can cause memory 16 problem[s].” (AR 394, 532.) He was observed to be “casually dressed, cooperative, and polite,” 17 with coherent and relevant speech. (AR 394, 532.) Plaintiff’s mood was “flat,” with “affect 18 congruent to mood.” (AR 394, 532.) His cognitive functions were within normal limits. (AR 394, 19 532.) Treatment notes from provider Madhav Suri, M.D. that same month discuss concerns about 20 “frontal lobe lesions.” (AR 579.) EEG results were normal. (AR 362–63.) 21 In December 2017, Plaintiff complained about anger issues since starting a new medication 22 and believed “the SSRI caused mania.” (AR 393, 531.) He reported obsessive compulsive disorder 23 (OCD) and depression symptoms. (AR 393, 531.) His examination results were the same as the 24 previous month. (AR 393, 531.) MRI results that month showed “[s]table nonspecific T2/FLAIR 25 hyperintensities,” “[n]o acute intercranial abnormality,” and mild paranasal sinus disease. (AR 26 357, 359.) 27 In January 2018, Plaintiff presented for a follow up appointment. (AR 392, 530.) He 28 reported that Seroquel was “working better” and that his sleep was “good.” (AR 392, 530.) He 1 was noted to be “doing well,” and his mental status examination results were normal. (AR 392, 2 530.) Plaintiff noted he was “doing better” with good sleep in March 2018. (AR 529.) His mental 3 status examination was normal, with normal cognitive functions. (AR 529.) Plaintiff was noted to 4 be “doing well.” (AR 529.) That same month, Dr. Suri noted Plaintiff’s anxiety and depression 5 was controlled with medication. (AR 381–82.) 6 Plaintiff presented for a psychological assessment by Steven C. Swanson, Ph.D., in March 7 2018. (AR 514–19.) He reported that he was involved in a “dune buggy” club, and enjoyed riding 8 these and dirt-bikes, boating, camping, and going to the beach. (AR 515.) Plaintiff reported feeling 9 “okay” and stated he was a “pretty laid-back person most days.” (AR 516.) During the 10 examination, Dr. Swanson described Plaintiff as “very talkative,” friendly, cooperative, and 11 “laughing happily” at times. (AR 516.) Plaintiff was able to maintain sufficient attention and 12 concentration on testing during the examination, and had average scores on both intelligence and 13 memory tests. (AR 516–18.) His mental and emotional function appeared to fall withing normal 14 limits, with “euthymic to euphoric” mood, full affect, normal thought content and form, and no 15 evidence of delusion. (AR 516, 518.) 16 That same month, Plaintiff underwent an independent medical evaluation by Michael M. 17 Bronshvag, M.D. (AR 553–60.) Although Plaintiff complained of dementia, Dr. Bronshvag found 18 that Plaintiff’s medical records “do not document or demonstrate dementia.” (AR 553, 555–56.) 19 Dr. Bronshvag found no evidence of any structural brain disease, atrophy, shrinkage, seizures, or 20 dementia. (AR 558.) According to Dr. Bronshvag, Plaintiff’s “MRI findings are at worst 21 nonspecific and most probably normal. The absence of any atrophy in the brain parenchyma is 22 incompatible with a demonstrated diagnosis of dementia.” (AR 558.) 23 Dr. Bronshvag administered the MOCA (Montreal Cognitive Assessment), on which 24 Plaintiff had some omissions, but was fully oriented and was noted with “very precise and articulate 25 memory and insight relevant to the history.” (AR 557.) Dr. Bronshvag noted that “the probability 26 is that the problem was volitional rather than brain damage.” (AR 557.) He observed that there 27 was clearly a dichotomy between his precisely provided history and his description of the difficulties he was having. To what extent that represents lack of 28 1 not answer at this time. Perhaps it might be most tactful to state that he was fully 2 cooperative, but his great concerns flavored the data he provided. 3 (AR 559–60.) 4 Plaintiff presented for treatment with Dwight W. Sievert, M.D. in April 2018. (AR 528, 5 653–57.) He complained of “front lobe dysfunction,” “mini strokes,” memory loss, fretfulness, 6 and irritability, and noted that he was “not doing well.” (AR 528, 653, 654.) His mood was “flat,” 7 but otherwise his mental status examination was normal, including normal cognitive functions. 8 (AR 528, 653.) Later in the month, he reported he was “doing well,” yet still had depressed effect 9 and obsessive symptoms. (AR 627, 656.) Plaintiff was also “doing ok” in May 2018, but 10 “wonder[ed] if he will get worse.” (AR 658.) In June 2018, Plaintiff reported to Dr. Sievert that 11 he was “doing well” with euthymic mood. (AR 638, 660.) 12 In August 2018, Plaintiff stated that he was “forgetful,” but “no worse than in [the] past.” 13 (AR 640.) He told Dr. Sievert that he “helped out” his aunt and dying uncle in a “nearby city.” 14 (AR 640.) In September 2018, Plaintiff transitioned to Trintellix, a new medication. (AR 664.) 15 He reported irritability, anxiety, depressed mood, and forgetfulness. (AR 664.) 16 Plaintiff was noted to be “doing well” and “elated” in October 2018 but with anxiety and 17 “depressed affect and depressed mood.” (AR 644, 666.) Dr. Sievert observed Plaintiff was “doing 18 ok but still down.” (AR 644, 666.) 19 In November 2018, Plaintiff was “irritable, fretful and doing so so [sic].” (AR 646, 668.) 20 He reported feeling “forgetful” and that he “cannot remember things and does not have 21 conversations.” (AR 646, 668.) Dr. Sievert observed Plaintiff was “doing ok” during that visit. 22 (AR 646, 668.) Later that month, Plaintiff was “doing fairly well” but still anxious and “somewhat 23 depressed.” (AR 648, 670.) Upon mental status examination by Dr. Sievert, he was observed to 24 be “doing well,” appropriately dressed, cooperative, polite, alert, and oriented. (AR 648, 670.) 25 Plaintiff’s speech was coherent and relevant. (AR 648, 670.) His mood was normal, with normal 26 orientation and cognitive functions. (AR 648, 670.) Dr. Sievert noted Plaintiff was “calm and 27 cooperative,” “alert and oriented,” and “doing well” in February 2019. (AR 649, 672.) His mental 28 status examination was normal, including normal cognitive functions. (AR 649, 672.) 1 In March 2019, Plaintiff’s mood was “generally ok,” and he was “doing well,” with normal 2 examination results as before. (AR 650, 674.) The same was true in May 2019, when Plaintiff 3 reported being “generally ok” but that he “felt better on Trintellix.” (AR 651, 676.) In June 2019, 4 Plaintiff reported “doing ok” and “functioning at a fair level,” but experiencing forgetfulness. (AR 5 652, 677.) Dr. Sievert noted a normal mental status examination, and that Plaintiff was 6 “cooperative and polite,” “alert and oriented” and “doing well” (AR 652, 677.) Plaintiff 7 complained of “feel[ing] badly” and having difficulty with his wife and stepchildren in August 8 2019. (AR 679.) Plaintiff’s mental status examination results were normal, with coherent and 9 rational thoughts, normal alertness and orientation, and normal cognitive functions. (AR 679.) Dr. 10 Sievert noted Plaintiff was “doing well.” (AR 679.) 11 Plaintiff complained of worsening depression in October 2019. (AR 681.) Dr. Sievert 12 found Plaintiff’s mental status examination results were normal and that he was “doing well,” with 13 normal mood, coherent and relevant speech, normal alertness and orientation, and normal cognitive 14 functions. (AR 681.) Plaintiff reported ceasing Trintellix, and taking Sertraline and Paroxetine. 15 (AR 681.) The treatment goals were indicated as “find antidepressant that works” and a referral 16 for transcranial magnetic stimulation. (AR 681.) 17 In November 2019, Plaintiff presented to Dr. Sievert for a follow up appointment. (AR 18 683.) He reported “doing ok,” but was concerned he could become more depressed due to recent 19 deaths of his friends. (AR 683.) His mental status examination was normal as before and he was 20 noted to be “doing well.” (AR 683.) Plaintiff reported to Dr. Sievert in December 2019 that he 21 was having “lots of difficulty” and did “not feel that he is able to do much.” (AR 684, 685.) Dr. 22 Sievert noted a normal mental status examination, including normal mood, normal alertness and 23 orientation, and normal cognitive functions, and stated that Plaintiff was “doing well.” (AR 684, 24 685.) 25 2. Opinion Evidence 26 In November 2017, Dr. Montana completed a two-page “Physician’s Report on Disability” 27 questionnaire. (AR 617–18.) His examination findings were that Plaintiff is “unable to focus and 28 concentrate” and “unable to perform the mental and memory requirements of his job.” (AR 617.) 1 Dr. Montana listed “cognitive dysfunction” and “anxiety and depression” as diagnoses, and opined 2 that Plaintiff is permanently “substantially incapacitated from performance of the usual duties of 3 the position for their current employer.” (AR 618.) In so opining, Dr. Montana observed Plaintiff 4 is “unable to perform the necessary evaluations, data collection, and analysis and application to his 5 job duties.” (AR 618.) 6 Following his examination of Plaintiff, Dr. Swanson opined in March 2018 that Plaintiff 7 is judged able to maintain concentration and relate appropriately to others in a job setting. He would be able to handle funds in his own best interests. He is expected 8 to understand, carry out, and remember simple instructions. He is judged able to 9 respond appropriately to usual work situations, such as attendance, safety, and the like. Changes in routine would not be very problematic for him. There do not 10 appear to be substantial restrictions in daily activities. Difficulties in maintaining social relationships do not appear to be present. 11 12 (AR 519.) 13 In September 2018, Dr. Sievert completed the same “Physician’s Report on Disability” 14 questionnaire as completed by Dr. Montana. (AR 540–41.) Plaintiff’s examination findings were 15 noted to be “poor memory” and “forgetfulness.” (AR 540.) Dr. Sievert diagnosed Plaintiff with 16 obsessive compulsive disorder, as evidenced by “muscle tension,” “anxiety,” and “repetitive 17 statements.” Plaintiff was also assessed with generalized anxiety, as he exhibited “tension” and 18 “worry,” and was “unable to tolerate stress.” (AR 540.) Dr. Sievert concluded that “memory loss 19 precludes work,” resulting in Plaintiff’s permanent incapacity “from the performance of the usual 20 duties of the position for their current employer.” (AR 541.) 21 Dr. Sievert completed another questionnaire in February 2020, titled “Medical Source 22 Statement of Ability to do Work-Related Activities (Mental).” (AR 686–88.) He found that 23 Plaintiff had “moderate” limitations in his ability to understand, remember, and carry out simple 24 instructions and his ability to make judgments on simple work-related decisions. (AR 686.) Dr. 25 Sievert opined that Plaintiff had “extreme” limitation in his ability to understand, remember, and 26 carry out complex instructions, and his ability to make judgments on complex work-related 27 decisions, due to his becoming “easily confused” with “poor memory.” (AR 686.) He also noted 28 moderate limitations in Plaintiff’s ability to interact appropriately with supervisor(s) and 1 coworkers, and extreme limitation in his ability to respond appropriately to usual work situations 2 and to changes in a routine work setting, all due to Plaintiff’s “anxiety” and “poor memory.” (AR 3 687.) 4 That same month, Dr. Schuyler completed the same questionnaire as Dr. Sievert. (AR 690– 5 91.) He found that Plaintiff had “marked” limitations in his ability to understand and remember 6 simple instructions; his ability to understand, remember, and carry out complex instructions; and 7 his ability to make judgments on complex work-related decisions, due to “neuropsychological 8 testing that showed significant problems with memory and executive functions in 2017 that have 9 reportedly grown worse, consistent with frontotemporal dementia.” (AR 690.) 10 B. Administrative Proceedings 11 The Commissioner denied Plaintiff’s application for benefits initially on March 22, 2018, 12 and again on reconsideration on May 14, 2018. (AR 116–26.) Consequently, Plaintiff requested 13 a hearing before an Administrative Law Judge (“ALJ”). (AR 133–47.) The ALJ conducted a 14 hearing on March 6, 2020. (AR 37–68.) Plaintiff appeared at the hearing with his attorney and 15 testified as to his alleged disabling conditions. (AR 42–59, 65–68.) A Vocational Expert (“VE”) 16 also testified at the hearing. (AR 59–64.) 17 C. The ALJ’s Decision 18 In a decision dated April 13, 2020, the ALJ found that Plaintiff was not disabled, as defined 19 by the Act. (AR 15–31.) The ALJ conducted the five-step disability analysis set forth in 20 C.F.R. 20 § 404.1520. (AR 17–31.) The ALJ decided that Plaintiff had not engaged in substantial gainful 21 activity since October 11, 2017, the amended alleged onset date (step one). (AR 17.) At step two, 22 the ALJ found Plaintiff’s following impairments to be severe: “degenerative disc disease; a 23 personality disorder; and substance abuse.” (AR 17–18.) Plaintiff did not have an impairment or 24 combination of impairments that met or medically equaled one of the listed impairments in 20 25 C.F.R. Part 404, Subpart P, Appendix 1 (“the Listings”) (step three). (AR 18–21.) 26 The ALJ then assessed Plaintiff’s residual functional capacity (RFC)4 and applied the 27 4 RFC is an assessment of an individual’s ability to do sustained work-related physical and mental activities in a work 28 setting on a regular and continuing basis of 8 hours a day, for 5 days a week, or an equivalent work schedule. TITLES 1 assessment at steps four and five. See 20 C.F.R. § 404.1520(a)(4) (“Before we go from step three 2 to step four, we assess your residual functional capacity . . . . We use this residual functional 3 capacity assessment at both step four and step five when we evaluate your claim at these steps.”). 4 The ALJ determined that Plaintiff had the RFC: 5 to perform medium work as defined in 20 CFR [§] 404.1567(c) except [Plaintiff] can frequently bend, stoop, kneel, crouch, and crawl. He can frequently climb 6 ramps and stairs, but cannot climb ladders, ropes, or scaffolds. [Plaintiff] can frequently reach overhead with his bilateral upper extremities. He is limited to 7 simple and routine tasks meaning that he is not capable of complex judgment or 8 analysis in the workplace (due to the side effects of pain and medication), and he can have frequent contact with supervisors, coworkers, and the public. He can 9 occasionally perform production rate tasks, and adapt to changes in the workplace, if they are simple and routine. 10 11 (AR 22–28.) Although the ALJ recognized that Plaintiff’s impairments “could reasonably be 12 expected to cause the alleged symptoms[,]” they rejected Plaintiff’s subjective testimony as “not 13 entirely consistent with the medical evidence and other evidence in the record for the reasons 14 explained in this decision.” (AR 23.) 15 The ALJ determined that Plaintiff could not perform his past work (step four) but that, given 16 his RFC, he retained the capacity to perform a significant number of other jobs in the local and 17 national economies (step five). (AR 29–30.) In making this determination, the ALJ posed a series 18 of hypothetical questions to the VE based upon Plaintiff’s RFC. (AR 60–65.) In response, the VE 19 testified that a person with the specified RFC could perform occupations such as automobile 20 detailer and courtesy clerk. (AR 61–62, 64–65.) Ultimately, the ALJ concluded that Plaintiff was 21 not disabled from October 11, 2017, through the date of their decision. (AR 31.) 22 Plaintiff sought review of this decision before the Appeals Council, which denied review 23 on October 14, 2020. (AR 1–6.) Therefore, the ALJ’s decision became the final decision of the 24 Commissioner. 20 C.F.R. § 404.981. 25 26 (S.S.A. July 2, 1996). The RFC assessment considers only functional limitations and restrictions that result from an 27 individual’s medically determinable impairment or combination of impairments. Id. “In determining a claimant’s RFC, an ALJ must consider all relevant evidence in the record including, inter alia, medical records, lay evidence, and 28 ‘the effects of symptoms, including pain, that are reasonably attributed to a medically determinable impairment.’” 1 2 A. Applicable Law 3 An individual is considered “disabled” for purposes of disability benefits if they are unable 4 “to engage in any substantial gainful activity by reason of any medically determinable physical or 5 mental impairment which can be expected to result in death or which has lasted or can be expected 6 to last for a continuous period of not less than 12 months.” 42 U.S.C. § 423(d)(1)(A). However, 7 “[a]n individual shall be determined to be under a disability only if [their] physical or mental 8 impairment or impairments are of such severity that [they] are not only unable to do [their] previous 9 work but cannot, considering [their] age, education, and work experience, engage in any other kind 10 of substantial gainful work which exists in the national economy.” Id. § 423(d)(2)(A). 11 “The Social Security Regulations set out a five-step sequential process for determining 12 whether a claimant is disabled within the meaning of the Social Security Act.” Tackett v. Apfel, 13 180 F.3d 1094, 1098 (9th Cir. 1999) (citing 20 C.F.R. § 404.1520); see also 20 C.F.R. § 416.920. 14 The Ninth Circuit has provided the following description of the sequential evaluation analysis: 15 In step one, the ALJ determines whether a claimant is currently engaged in substantial gainful activity. If so, the claimant is not disabled. If not, the ALJ 16 proceeds to step two and evaluates whether the claimant has a medically severe 17 impairment or combination of impairments. If not, the claimant is not disabled. If so, the ALJ proceeds to step three and considers whether the impairment or 18 combination of impairments meets or equals a listed impairment under 20 C.F.R. pt. 404, subpt. P, [a]pp. 1. If so, the claimant is automatically presumed disabled. If 19 not, the ALJ proceeds to step four and assesses whether the claimant is capable of 20 performing [their] past relevant work. If so, the claimant is not disabled. If not, the ALJ proceeds to step five and examines whether the claimant has the [RFC] . . . to 21 perform any other substantial gainful activity in the national economy. If so, the claimant is not disabled. If not, the claimant is disabled. 22 23 Burch v. Barnhart, 400 F.3d 676, 679 (9th Cir. 2005); see, e.g., 20 C.F.R. § 416.920(a)(4) 24 (providing the “five-step sequential evaluation process” for SSI claimants). “If a claimant is found 25 to be ‘disabled’ or ‘not disabled’ at any step in the sequence, there is no need to consider subsequent 26 steps.” Tackett, 180 F.3d at 1098 (citing 20 C.F.R. § 404.1520); 20 C.F.R. § 416.920. 27 “The claimant carries the initial burden of proving a disability in steps one through four of 28 the analysis.” Burch, 400 F.3d at 679 (citing Swenson v. Sullivan, 876 F.2d 683, 687 (9th Cir. 1 1989)). “However, if a claimant establishes an inability to continue [their] past work, the burden 2 shifts to the Commissioner in step five to show that the claimant can perform other substantial 3 gainful work.” Id. (citing Swenson, 876 F.2d at 687). 4 B. Scope of Review 5 “This court may set aside the Commissioner’s denial of [social security] benefits [only] 6 when the ALJ’s findings are based on legal error or are not supported by substantial evidence in 7 the record as a whole.” Tackett, 180 F.3d at 1097 (citation omitted). “Substantial evidence” means 8 “such relevant evidence as a reasonable mind might accept as adequate to support a conclusion.” 9 Richardson v. Perales, 402 U.S. 389, 401 (1971) (quoting Consol. Edison Co. of N.Y. v. NLRB, 10 305 U.S. 197, 229 (1938)). “Substantial evidence is more than a mere scintilla but less than a 11 preponderance.” Ryan v. Comm’r of Soc. Sec., 528 F.3d 1194, 1198 (9th Cir. 2008). 12 “This is a highly deferential standard of review . . . .” Valentine v. Comm’r of Soc. Sec. 13 Admin., 574 F.3d 685, 690 (9th Cir. 2009). The ALJ’s decision denying benefits “will be disturbed 14 only if that decision is not supported by substantial evidence or it is based upon legal error.” 15 Tidwell v. Apfel, 161 F.3d 599, 601 (9th Cir. 1999). Additionally, “[t]he court will uphold the 16 ALJ’s conclusion when the evidence is susceptible to more than one rational interpretation.” Id.; 17 see, e.g., Edlund v. Massanari, 253 F.3d 1152, 1156 (9th Cir. 2001) (“If the evidence is susceptible 18 to more than one rational interpretation, the court may not substitute its judgment for that of the 19 Commissioner.”) (citations omitted). 20 In reviewing the Commissioner’s decision, the Court may not substitute its judgment for 21 that of the Commissioner. Macri v. Chater, 93 F.3d 540, 543 (9th Cir. 1996). Instead, the Court 22 must determine whether the Commissioner applied the proper legal standards and whether 23 substantial evidence exists in the record to support the Commissioner’s findings. See Lewis v. 24 Astrue, 498 F.3d 909, 911 (9th Cir. 2007). Nonetheless, “the Commissioner’s decision ‘cannot be 25 affirmed simply by isolating a specific quantum of supporting evidence.’” Tackett, 180 F.3d at 26 1098 (quoting Sousa v. Callahan, 143 F.3d 1240, 1243 (9th Cir. 1998)). “Rather, a court must 27 ‘consider the record as a whole, weighing both evidence that supports and evidence that detracts 28 from the [Commissioner’s] conclusion.’” Id. (quoting Penny v. Sullivan, 2 F.3d 953, 956 (9th Cir. 1 1993)). 2 Finally, courts “may not reverse an ALJ’s decision on account of an error that is harmless.” 3 Molina v. Astrue, 674 F.3d 1104, 1111 (9th Cir. 2012) (citing Stout v. Comm’r, Soc. Sec. Admin., 4 454 F.3d 1050, 1055–56 (9th Cir. 2006)). Harmless error “exists when it is clear from the record 5 that ‘the ALJ’s error was inconsequential to the ultimate nondisability determination.’” 6 Tommasetti v. Astrue, 533 F.3d 1035, 1038 (9th Cir. 2008) (quoting Robbins v. Soc. Sec. Admin., 7 466 F.3d 880, 885 (9th Cir. 2006)). “[T]he burden of showing that an error is harmful normally 8 falls upon the party attacking the agency’s determination.” Shinseki v. Sanders, 556 U.S. 396, 409 9 (2009) (citations omitted). 10 IV. DISCUSSION 11 Plaintiff contends that the ALJ committed harmful error in failing to consider his 12 “neurocognitive impairment” severe at step two by “cherry-picking” evidence unfavorable to him. 13 (See Doc. 17 at 6–10; Doc. 21 at 1–4.) The Court disagrees. 14 A. Legal Standard 15 At step two of the sequential evaluation, the ALJ determines which of Plaintiff’s alleged 16 impairments are “severe” within the meaning of 20 C.F.R. § 404.1520(c). A severe impairment is 17 one that “significantly limits” a claimant’s “physical or mental ability to do basic work activities.” 18 Id. An ALJ must consider all the evidence at step two to determine whether a medically 19 determinable impairment significantly limits the claimant’s ability to perform basic work activities. 20 Id. §§ 404.1520(a), 416.920(a); Bowen v. Yuckert, 482 U.S. 137, 153 (1987). “An impairment or 21 combination of impairments may be found ‘not severe only if the evidence establishes a slight 22 abnormality that has no more than a minimal effect on an individual’s ability to work.’” Webb v. 23 Barnhart, 433 F.3d 683, 686–87 (9th Cir. 2005) (quoting Social Security Ruling (“SSR”) 96–3p 24 (1996)). The purpose of step two is to operate as “a de minimis screening device to dispose of 25 groundless claims.” Smolen v. Chater, 80 F.3d 1273, 1290 (9th Cir. 1996); see also Hoopai v. 26 Astrue, 499 F.3d 1071, 1076 (9th Cir. 2007) (the step two finding is “merely a threshold 27 determination” that “only raises a prima facie case of a disability.”); Buck v. Berryhill, 869 F.3d 28 1040, 1048–49 (9th Cir. 2017) (“Step two is merely a threshold determination meant to screen out 1 weak claims. It is not meant to identify the impairments that should be taken into account when 2 determining the RFC.”) (internal citations omitted). The plaintiff bears the burden of proof at step 3 two to show that an impairment qualifies as severe. Bowen, 482 U.S. at 146 n.5. 4 B. The ALJ Did Not Err at Step Two 5 In support of argument that the ALJ erred at step two by failing to deem Plaintiff’s 6 neurocognitive impairment severe, Plaintiff relies on the limitations opined by consultative 7 examiners Drs. Sievert, Montana, and Schuyler.5 (See Doc. 17 at 6–10; Doc. 21 at 1–4.) 8 1. Medical Opinion Evidence Generally 9 Plaintiff’s claim is governed by the agency’s “new” regulations concerning how ALJs must 10 evaluate medical opinions for claims filed on or after March 27, 2017. 20 C.F.R. § 404.1520c. The 11 regulations set “supportability” and “consistency” as “the most important factors” when 12 determining the opinions’ persuasiveness. 20 C.F.R. § 404.1520c(b)(2). Although the regulations 13 eliminate the “physician hierarchy,” deference to specific medical opinions, and assigning “weight” 14 to a medical opinion, the ALJ must still “articulate how [they] considered the medical opinions” 15 and “how persuasive [they] find all of the medical opinions.” 20 C.F.R. § 404.1520c(a)–(b). 16 Recently, the Ninth Circuit issued the following guidance regarding treatment of 17 physicians’ opinions after implementation of the revised regulations: 18 The revised social security regulations are clearly irreconcilable with our caselaw according special deference to the opinions of treating and examining physicians on 19 account of their relationship with the claimant. See 20 C.F.R. § 404.1520c(a) (“We will not defer or give any specific evidentiary weight, including controlling weight, 20 to any medical opinion(s) . . . , including those from your medical sources.”). Our 21 requirement that ALJs provide “specific and legitimate reasons” for rejecting a treating or examining doctor’s opinion, which stems from the special weight given 22 to such opinions, see Murray, 722 F.2d at 501–02, is likewise incompatible with the revised regulations. Insisting that ALJs provide a more robust explanation when 23 discrediting evidence from certain sources necessarily favors the evidence from those sources—contrary to the revised regulations. 24 25 Woods v. Kijakazi, 32 F.4th 785, 792 (9th Cir. 2022). Under the new regulations, “the decision to 26 discredit any medical opinion, must simply be supported by substantial evidence.” Id. at 787. 27 28 5 Plaintiff also relies on his subjective complaints to establish limitations in his cognitive functioning (see Doc. 17 at 1 In conjunction with this requirement, “[t]he agency must ‘articulate . . . how persuasive’ it 2 finds ‘all of the medical opinions’ from each doctor or other source, 20 C.F.R. § 404.1520c(b), and 3 ‘explain how [it] considered the supportability and consistency factors’ in reaching these findings, 4 id. § 404.1520c(b)(2).” Woods, 32 F.4th at 792. “Supportability means the extent to which a 5 medical source supports the medical opinion by explaining the ‘relevant . . . objective medical 6 evidence.’” Id. at 791–92 (quoting 20 C.F.R. § 404.1520c(c)(1)) “Consistency means the extent 7 to which a medical opinion is ‘consistent . . . with the evidence from other medical sources and 8 nonmedical sources in the claim.’” Id. at 792 (quoting 20 C.F.R. § 404.1520c(c)(2)). 9 As the Ninth Circuit also observed, 10 The revised regulations recognize that a medical source’s relationship with the claimant is still relevant when assessing the persuasiveness of the source’s opinion. 11 See id. § 404.1520c(c)(3). Thus, an ALJ can still consider the length and purpose of the treatment relationship, the frequency of examinations, the kinds and extent of 12 examinations that the medical source has performed or ordered from specialists, and whether the medical source has examined the claimant or merely reviewed the 13 claimant’s records. Id. § 404.1520c(c)(3)(i)–(v). However, the ALJ no longer needs 14 to make specific findings regarding these relationship factors: 15 Woods, 32 F.4th at 792. “A discussion of relationship factors may be appropriate when ‘two or 16 more medical opinions . . . about the same issue are . . . equally well-supported . . . and consistent 17 with the record . . . but are not exactly the same.’” Id. (quoting § 404.1520c(b)(3)). “In that case, 18 the ALJ ‘will articulate how [the agency] considered the other most persuasive factors.’” Id. 19 Lastly, if the medical opinion includes evidence on an issue reserved to the Commissioner, the ALJ 20 need not provide an analysis of the evidence in his decision, even in the discussions required by 20 21 C.F.R. § 404.1520c. See 20 C.F.R. §§ 404.1520b(c)(3). 22 With these legal standards in mind, the Court reviews the weight given to Drs. Sievert’s, 23 Montana’s, and Schuyler’s opinions. 24 2. Analysis 25 a. Dr. Sievert 26 In finding Dr. Sievert’s September 2018 opinion related to Plaintiff’s mental functioning 27 “not persuasive,” the ALJ reasoned as follows: 28 This opinion is on an ultimate issue of the case, and is reserved to the Commissioner. 1 statement that “memory loss preludes work” (Ex. 15F, 2). This is not consistent 2 with the examination of the consultative examiner and the independent medical examiner. Specifically, the claimant’s’ normal intelligence and memory testing 3 during the consultative examination, and Dr. Bronshvags’ conclusion that there was no evidence of dementia, lobe issues, and no documented or demonstrated structural 4 brain disease (Ex. 15F, 19). 5 (AR 27.) As to Dr. Sievert’s February 2020 opinion, the ALJ deemed it “not persuasive” because 6 it is 7 grossly inconsistent with the evidence. Specifically, it is inconsistent with the claimant’s normal intelligence and memory testing during the consultative 8 examination, inconsistent with imaging of his brain with no acute findings, and 9 inconsistent with the opinion of the independent medical examiner that there was no evidence of dementia or structural brain disease (Ex. 3F, 2, 8; 9F; 15F, 19). 10 Dr. Sievert’s opinion is also not supported by his own treatment notes, where the claimant was chronicled with normal cognitive functioning throughout 2018 and 11 2019 (Ex. 5F, 1-3; 19F, 1; 20F). Additionally, his opinion is inconsistent with 12 evidence that the claimant remains active with a “dune buggy” club, and evidence that the claimant’s memory symptoms may be secondary to his history of 13 benzodiazepine dependency (Ex. 5F, 3; 9F, 3). 14 (AR 27–28.) 15 As an initial matter, Dr. Sievert’s conclusion in September 2018 that Plaintiff’s “memory 16 loss” renders him permanently incapacitated “from the performance of the usual duties of the 17 position for their current employer” (AR 541) does not assess any specific work-related function, 18 and does not constitute a “medical opinion” under 20 C.F.R. § 404.1513(a)(2). The ALJ was 19 therefore not required to articulate how persuasive he considered the evidence to be, or to otherwise 20 address Dr. Sievert’s disability determination in the written decision. See 20 C.F.R. § 21 404.1520b(c)(3)(i). 22 Nevertheless, the ALJ did evaluate the supportability and consistency of both of Dr. 23 Sievert’s opinions, and did so properly. As to supportability, the ALJ appropriately considered Dr. 24 Sievert’s failure to adequately explain his reasoning for his September 2018 opinion. See 20 C.F.R. 25 § 404.1520c(c)(1) (requiring the ALJ to consider “supporting explanations presented by a medical 26 source.”). As the ALJ observed, Dr. Sievert’s September 2018 opinion was cursory in nature, 27 stating only that “memory loss precludes work.” (AR 27, 541) The lack of supporting explanation 28 was a proper consideration in evaluating the supportability of Dr. Sievert’s September 2018 1 opinion. See 20 C.F.R. § 404.1520c(c)(1); Woods, 32 F.4th at 794 (substantial evidence supported 2 finding that medical opinion, expressed in a “fill-in-the-blank questionnaire,” was “not persuasive 3 because it is not supported by any explanation” or “pertinent exam findings.”); Ponce v. Comm’r 4 of Soc. Sec., No. 1:20-CV-01664-EPG, 2022 WL 196529, at *3 (E.D. Cal. Jan. 21, 2022) (declining 5 to find the ALJ erroneously rejected medical opinion where given on a “checkbox form with no 6 significant narrative explanation” and “no citation to record evidence.”). 7 The ALJ determined Dr. Sievert’s February 2020 opinion concerning Plaintiff’s “extreme” 8 mental limitations was not supported by his own treatment notes and objective findings. For 9 example, as cited by the ALJ, Dr. Sievert routinely found Plaintiff exhibited “normal cognitive 10 functions” throughout 2018 and 2019, including during a visit that took place two months before 11 rendering his opinion. (See AR 528, 653 (April 2018); AR 648, 670 (November 2018); AR 649, 12 672 (February 2019); AR 650, 674 (March 2019); AR 651, 676 (May 2019); AR 652, 677 (June 13 2019); AR 679 (August 2019); AR 681 (October 681); AR 683 (November 2019); and AR 684, 14 685 (December 2019).) As the ALJ observed elsewhere in the opinion, Dr. Sievert consistently 15 documented Plaintiff’s status as “doing well” throughout this time period. (See id.) The lack of 16 support by Dr. Sievert’s own treatment notes and objective findings was a proper consideration in 17 evaluating the supportability of his opinion. See, e.g., Trezona v. Comm’r of Soc. Sec., No. 1:21- 18 CV-00792-EPG, 2022 WL 1693493, at *3 (E.D. Cal. May 26, 2022); Amanda B. v. Comm’r, Soc. 19 Sec. Admin., No. 1:20-CV-01507-YY, 2022 WL 972408, at *7 (D. Or. Mar. 31, 2022). 20 As to consistency, the ALJ found Dr. Sievert’s opinions concerning Plaintiff’s mental 21 limitations was generally inconsistent with the other medical evidence. As cited by the ALJ, 22 Plaintiff had average scores on both intelligence and memory tests performed by Dr. Swanson in 23 March 2018. (AR 516–18.) In addition, Dr. Bronshvag’s review in that same month of Plaintiff’s 24 medical records and MRI testing found no evidence of any structural brain disease, atrophy, 25 shrinkage, seizures, or dementia. (AR 558.) 26 b. Dr. Montana 27 The Court finds that the ALJ also properly evaluated the supportability and consistency of 28 1 Dr. Montana’s opinion.6 Finding the opinion “not persuasive,” the ALJ correctly observed that it 2 is “the same ‘check box’ form that Dr. Sievert submitted” and found it “likewise inconsistent with 3 the noted medical references above, as well as being flatly contradicted by [Plaintiff’s] admitted 4 vigorous activities of daily living.” (AR 27.) Dr. Montana does not explain how “psychological 5 testing” results support Plaintiff’s inability to “perform the mental and memory requirements of his 6 job,” particularly given that no such testing was performed on July 24, 2017, the date specified. 7 (See AR 617. See also AR 590–92.) This opinion is also undermined by Dr. Montana’s own 8 treatment notes from the prior month, where he noted his mental examination of Plaintiff was 9 normal, with normal mood, affect, and behavior. (AR 352, 377.) 10 The ALJ also reasonably found the opinion inconsistent with Plaintiff’s average 11 performance on intelligence and memory tests in March 2018 (AR 516–18) and lack of objective 12 evidence of any structural brain disease, atrophy, shrinkage, seizures, or dementia (AR 558), as 13 discussed above, as well as Plaintiff’s “vigorous” activities of daily living that post-date the 14 opinion, which include participation in a “dune buggy” club, riding dune buggies and dirt-bikes, 15 boating, camping, and going to the beach. (AR 515.) See, e.g., Zalomski v. Comm’r of Soc. Sec. 16 Admin., No. CV-21-00417-PHX-MTL, 2022 WL 2816809, at *3 (D. Ariz. July 19, 2022) (ALJ 17 properly found medical opinion inconsistent with Plaintiff’s activities of daily living). See also 20 18 C.F.R. § 404.1520c(c)(2). 19 c. Dr. Schuyler 20 Finally, the ALJ evaluated Dr. Schuyler’s opinion as follows: 21 This opinion is also not persuasive. Dr. Schuyler does cite the 2017 testing which showed some problems with verbal memory, which does somewhat support his 22 opinion (Ex. 15F, 12). However, he also cites [Plaintiff’s] symptoms as being 23 “consistent with frontotemporal dementia,” but, as discussed at length above, there is no evidence of “frontotemporal dementia” in the record. Further, his opinion is 24 inconsistent with [Plaintiff’s] normal intelligence and memory testing during the consultative examination, inconsistent with imaging of his brain, and inconsistent 25 with opinion of the independent medical examiner, that there was no evidence of dementia or structural brain disease (Ex. 3F, 2, 8; 9F; 15F, 19). His opinion is further 26 27 6 Like Dr. Sievert’s, Dr. Montana’s opinion that Plaintiff is permanently “substantially incapacitated from performance 28 of the usual duties of the position for their current employer” (AR 618) is a determination reserved to the 1 with normal cognitive functioning throughout 2018 and 2019 (Ex. 5F, 1-3; 19F, 1; 2 20F). Additionally, his opinion is inconsistent with evidence that the claimant remains active with a “dune buggy” club, and evidence that the claimant’s memory 3 symptoms may be secondary to his history of benzodiazepine dependency. 4 (AR 28.) The Court concludes that the ALJ properly evaluated the supportability and consistency 5 of Dr. Schuyler’s opinion. As to supportability, the ALJ appropriately found Plaintiff’s October 6 2017 testing, while showing some difficulties with verbal memory (see AR 551), was an 7 insufficient basis from which to find “marked” limitations in Plaintiff’s ability to understand, 8 remember, and carry out instructions. (See AR 690.) As support for his opinion, Dr. Schuyler 9 states that Plaintiff’s “problems with memory and executive functions” have “reportedly grown 10 worse,” but identifies no evidence in the record to substantiate such “reports,” leaving one to 11 conclude that it is based on Plaintiff’s own subjective reporting (which the ALJ discredited). 12 Dr. Schuyler’s finding that Plaintiff’s condition was worsening and “consistent with 13 frontotemporal dementia” is also inconsistent with the medical evidence during the relevant period. 14 As detailed above, Plaintiff consistently exhibited “normal cognitive functions” during mental 15 status examinations and had average scores on both intelligence and memory tests. Both treatment 16 records and objective (MRI) testing demonstrated no evidence of any structural brain disease, 17 atrophy, shrinkage, seizures, or dementia. The ALJ also correctly observed that Plaintiff’s daily 18 activities, described above, further undermine Dr. Schuyler’s conclusions. 19 Plaintiff is correct that the ALJ must not “cherry-pick” instances of no or low 20 symptomology without considering the context, such as instances of high symptomology. See 21 Reddick v. Chater, 157 F.3d 715, 722-23 (9th Cir. 1998) (an ALJ must not “cherry-pick” certain 22 observations without considering their context); see also Attmore v. Colvin, 827 F.3d 872, 875 (9th 23 Cir. 2016) (quoting Tackett, 180 F.3d at 1098) (the Court “cannot affirm . . . ‘simply by isolating a 24 specific quantum of supporting evidence,’ but ‘must consider the record as a whole, weighing both 25 evidence that supports and evidence that detracts’). The Court does not however concur with 26 Plaintiff that the ALJ committed this error. To the contrary, the Court finds Plaintiff’s invitation 27 to focus on records that support his “severe neurocognitive impairments,” without mentioning the 28 1 normal findings therein, the very definition of prohibited cherry-picking. (See Doc. 17 at 10 (citing 2 AR 333, 339, 351, 365, 369, 376, 481, 640, 642, 646, 651, 652, 654, 658, 662, 668, 676, 677).) 3 The Court declines, as doing so is incongruous with the intent of the Social Security Act. See e.g., 4 White v. Comm’r Soc. Sec., 572 F.3d 272, 285 (6th Cir. 2009) (“The problem with [plaintiff’s] 5 cherry picking argument, however, is that it cuts both ways. She too cherry picks data.”). 6 In sum, while the medical record reflects that Plaintiff has “moderate mental health 7 limitations” (see AR 26), it was reasonable for the ALJ to conclude that the record did not support 8 the severity of the restrictions opined by Drs. Sievert, Montana, and Schuyler. That these opinions 9 lacked support and were inconsistent with the medical evidence were legally sufficient findings 10 based on substantial evidence. The fact that Plaintiff’s course of treatment could be interpreted 11 differently has no effect on this Court’s ruling. See Andrews v. Shalala, 53 F.3d 1035, 1039–40 12 (9th Cir. 1995) (“The ALJ is responsible for determining credibility, resolving conflicts in medical 13 testimony, and for resolving ambiguities. We must uphold the ALJ’s decision where the evidence 14 is susceptible to more than one rational interpretation.”) (citations omitted). See also Batson v. 15 Comm’r Soc. Sec. Admin., 359 F.3d 1190, 1198 (9th Cir. 2004) (“When the evidence before the 16 ALJ is subject to more than one rational interpretation, [the Court] must defer to the ALJ’s 17 conclusion.”). Thus, the ALJ did not err by finding the opinions of Drs. Sievert, Montana, and 18 Schuyler not persuasive. 19 C. Even Assuming Arguendo the ALJ Did Err, Such Error was Harmless 20 Even had the ALJ erred by failing to conclude, based on Drs. Sievert’s, Montana’s, and/or 21 Schuler’s opinions, that Plaintiff had a severe neurocognitive impairment, the Court agrees with 22 the Commissioner that such error was at most harmless. A claimant is prejudiced at step two by 23 an ALJ’s omission of an impairment only where that step is not resolved in the claimant’s favor. 24 See Burch, 400 F.3d at 682 (“Here, the ALJ did not find that Burch’s obesity was a ‘severe’ 25 impairment . . . . Assuming without deciding that this omission constituted legal error, it could only 26 have prejudiced Burch in step three (listing impairment determination) or step five (RFC) because 27 the other steps, including this one, were resolved in her favor.”); see also Hickman v. Comm’r, 399 28 F. App’x 300, 302 (9th Cir. 2010) (“Any error in the ALJ’s failure to include a reading disorder as 1 one of Hickman’s severe impairments at step two of the analysis is harmless. The ALJ found 2 Hickman suffered from other severe impairments and, thus, step two was already resolved in 3 Hickman’s favor.”). Additionally, the failure to include an impairment in the step two analysis is 4 harmless if the ALJ considers the functional limitations that flow from said impairment in 5 subsequent steps. See Lewis v. Astrue, 498 F.3d 909, 911 (9th Cir. 2007) (holding that ALJ’s failure 6 to list plaintiff’s bursitis as a severe impairment at step two was harmless where ALJ considered 7 limitations caused by the condition at step four); see also Molina, 674 F.3d at 1115 (error is 8 harmless “where it is inconsequential to the [ALJ’s] ultimate nondisability determination”). 9 Step two was resolved in Plaintiff’s favor when the ALJ determined that his severe 10 impairments included degenerative disc disease, a personality disorder, and substance abuse; the 11 ALJ then proceeded to the step three analysis. (AR 17–18.). It follows that, since Plaintiff’s claims 12 were not screened out at this step, he was not prejudiced by any error in the step two analysis. The 13 ALJ went on to state in her RFC findings that they “considered all symptoms and the extent to 14 which these symptoms can reasonably be accepted as consistent with the objective medical 15 evidence . . . .” (AR 22; see, e.g., Sara Ann W. v. Comm’r of Soc. Sec., No. 2:17-CV-00277-RHW, 16 2018 WL 4088771, at *4 (E.D. Wash. Aug. 27, 2018) (“[T]he ALJ specifically noted that she 17 considered all symptoms in assessing the residual functional capacity. Accordingly, the Court finds 18 the ALJ did not err in the step two analysis, and if any error did occur it was harmless.”).) In fact, 19 the ALJ’s evaluation of Drs. Sievert’s, Montana’s, and Schuyler’s opinions took place after step 20 two, in the context of assessing Plaintiff’s RFC at step four. (See AR 27–28.) 21 Plaintiff does not address the Commissioner’s harmlessness argument. (See Doc. 20 at 18– 22 19.) Nor does he identify any evidence, other than the above-described medical opinions and his 23 unchallenged discredited complaints, demonstrating that his neurocognitive impairments caused 24 alleged limitations that were not accounted for in his RFC. The Court finds that the ALJ properly 25 weighed the medical evidence, the opinion evidence, and Plaintiff’s symptom claims and, as a 26 result, the RFC incorporated the “moderate mental health limitations” that were supported by 27 substantial evidence in the record (see AR 26), like his problems with verbal memory (see AR 28 551). This includes Plaintiff’s limitations to “simple and routine tasks,” in that he is “not capable 1 of complex judgment or analysis in the workplace,” and occasional performance of production rate 2 tasks and adaptation to changes in the workplace, so long as they are “simple and routine.” (AR 3 22.) 4 V. CONCLUSION AND ORDER 5 After consideration of Plaintiff’s and the Commissioner’s briefs and a thorough review of 6 the record, the Court finds that the ALJ’s decision is supported by substantial evidence and is 7 therefore AFFIRMED. The Clerk of this Court is DIRECTED to enter judgment in favor of 8 Defendant Kilolo Kijakazi, Acting Commissioner of Social Security, and against Plaintiff. 9 IT IS SO ORDERED. 10 11 Dated: August 29, 2022 /s/ Sheila K. Oberto . UNITED STATES MAGISTRATE JUDGE 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
Document Info
Docket Number: 1:20-cv-01753
Filed Date: 8/30/2022
Precedential Status: Precedential
Modified Date: 6/20/2024